These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 38099569

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 27. Growth, growth potential, and influences on adult height in the transgender and gender-diverse population.
    Roberts SA, Carswell JM.
    Andrology; 2021 Nov; 9(6):1679-1688. PubMed ID: 33969625
    [Abstract] [Full Text] [Related]

  • 28. Determinants of Bone Mass Accrual in Transgender and Gender Diverse Youth Undergoing Pubertal Suppression Therapy.
    Roberge S, Roberge T, Corathers S, Nasomyont N.
    J Clin Densitom; 2024 Nov; 27(3):101505. PubMed ID: 38936233
    [Abstract] [Full Text] [Related]

  • 29. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM.
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation.
    Turban JL, King D, Carswell JM, Keuroghlian AS.
    Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31974216
    [Abstract] [Full Text] [Related]

  • 33. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Management of juvenile gender dysphoria.
    Hembree WC.
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
    [Abstract] [Full Text] [Related]

  • 38. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
    Salerno M, Di Maio S, Gasparini N, Mariano A, Macchia V, Tenore A.
    Horm Res; 1998 Dec; 50(4):205-11. PubMed ID: 9838241
    [Abstract] [Full Text] [Related]

  • 39. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C, Martínez de Osaba MJ, Martínez S, Fortuny A.
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [Abstract] [Full Text] [Related]

  • 40. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
    Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG.
    J Clin Endocrinol Metab; 2017 Nov 01; 102(11):3869-3903. PubMed ID: 28945902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.